KORU Medical Systems (KRMD) Stock Analysis & Winston Score

KORU Medical Systems makes medical devices that help patients receive liquid nutrition and medication at home instead of in a hospital. Its main product is the FREEDOM Infusion System, a lightweight, portable pump and supply kit used for subcutaneous infusion — delivering fluids under the skin rather than through a vein. The company sells primarily to patients with conditions like primary immunodeficiency, who need regular infusions of immunoglobulin therapy. KORU Medical earns revenue by selling its infusion pumps and the disposable supplies that go with them, such as tubing and needles, which creates a recurring revenue stream each time a patient refills their supplies. The company operates mainly in the United States and is small, with a market cap around $200 million. Its competitive position depends on its niche focus on subcutaneous delivery, which is simpler and more comfortable than intravenous infusion. The key growth driver is expanding adoption among home infusion providers and patients, but the company is currently unprofitable, meaning it must grow revenue faster than its costs to reach sustainability.